ArticleCureus2024
Prognostic Value of Admission Lactate Levels in Critically Ill Patients: A Comparative Study With Sequential Organ Failure Assessment and Acute Physiology and Chronic Health Evaluation II Scores.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07712328 (A Randomized, Controlled, Open-Label Clinical Trial of Prophylactic Intraoperative Desmopressin), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Controlled, Open-Label Clinical Trial of Prophylactic Intraoperative Desmopressin (dDAVP) in Patients Undergoing Surgery for Complex Sellar Region Tumors
Who cites it
4 citing papers in PubMed.
- Article
- Analysis of influencing factors and construction of nomogram prediction model for pulmonary infection in patients with acute exacerbation of chronic obstructive pulmonary disease complicated with type II respiratory failure.Frontiers in medicine · 2026Article
- Beyond SOFA and APACHE II, Novel Risk Stratification Models Using Readily Available Biomarkers in Critical Care.Diagnostics (Basel, Switzerland) · 2025Article
- Lactate Is a Strong Predictor of Poor Outcomes in Patients with Severe Traumatic Brain Injury.Biomedicines · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Critical illness refers to life-threatening conditions requiring mechanical or pharmacological intervention to maintain organ function. Prognostic models, such as the Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores, have been widely used to predict mortality in intensive care unit (ICU) patients. Lactate levels are emerging as a valuable biomarker in this context. This study aims to determine the prognostic value of lactate levels upon admission in critically ill patients and to assess their correlation with SOFA and APACHE II scores. Methods This descriptive cross-sectional study included 200 critically ill patients admitted to the emergency department over one year. Data on patient demographics, clinical findings, and laboratory results were collected, and lactate levels and SOFA and APACHE II scores were measured at the time of admission. Patients were followed throughout their hospital stay, with outcomes classified as survival or mortality. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive value of lactate, SOFA, and APACHE II scores. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 27.0 (Released 2020; IBM Corp., Armonk, New York, United States). Results The mean age of the patients was 56.8±16.9 years; 110 (55%) were men, and 90 (45%) were women. In total, 79 patients (39.5%) were non-survivors, and 121 (60.5%) were survivors. Lactate levels were significantly higher in non-survivors (3.56±1.90 mmol/L) compared to survivors (1.47±0.82 mmol/L) (p<0.001). The SOFA and APACHE II scores were also significantly higher in non-survivors (SOFA: 6.35±3.19; APACHE II: 19.91±8.21) than in survivors (SOFA: 3.14±2.02; APACHE II: 12.45±5.76) (p<0.001). The ROC curve analysis showed that lactate had an area under the curve (AUC) of 0.909, SOFA had an AUC of 0.809, and APACHE II had an AUC of 0.769 for predicting mortality. Conclusions Lactate levels are a highly sensitive predictor of mortality in critically ill patients, with significant correlations to SOFA and APACHE II scores. Lactate, as a single rapid test, provides substantial prognostic information and can aid in early triage and clinical decision-making, particularly in resource-limited settings. A single arterial lactate measurement at admission is an effective tool for predicting patient outcomes in the ICU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.